EXACT Sciences Corp. Reaches New 12-Month High at $14.85 (EXAS)
EXACT Sciences Corp. (NASDAQ:EXAS) set a new 52-week high on Monday, American Banking and Market News reports. The company traded as high as $14.85 and last traded at $13.88, with a volume of 1,439,932 shares. The stock had previously closed at $13.96.
Several analysts have recently commented on the stock. Analysts at Maxim Group reiterated a “sell” rating on shares of EXACT Sciences Corp. in a research note to investors on Tuesday, October 29th. Analysts at Wedbush upgraded shares of EXACT Sciences Corp. from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, October 16th. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $17.38.
In other EXACT Sciences Corp. news, COO Maneesh Arora unloaded 8,627 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $11.96, for a total transaction of $103,178.92. Following the completion of the sale, the chief operating officer now directly owns 61,292 shares in the company, valued at approximately $733,052. The transaction was disclosed in a document filed with the SEC, which is available at this link.
EXACT Sciences Corp. has a one year low of $6.93 and a one year high of $14.70. The stock’s 50-day moving average is $12.30 and its 200-day moving average is $12.24. The company’s market cap is $995.0 million.
EXACT Sciences Corp. (NASDAQ:EXAS) last announced its earnings results on Tuesday, October 29th. The company reported ($0.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.18) by $0.02. The company had revenue of $1.00 million for the quarter, compared to the consensus estimate of $1.02 million. During the same quarter last year, the company posted ($0.21) earnings per share. EXACT Sciences Corp.’s revenue was up .0% compared to the same quarter last year. On average, analysts predict that EXACT Sciences Corp. will post $-0.71 earnings per share for the current fiscal year.
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.